Abstract:Abstract Acute kidney injury (AKI) is a public health problem with no specific therapies in the clinic, and the underlying pathogenesis of AKI remains obscure. Bombesin receptor-activated protein(BRAP, C6ORF89 protein) was initially discovered as a ligand for a previously orphan G protein-coupled receptor bombesin-like receptor-3. At present, accepted biological effects of BRAP include cell cycle progression, wound repair, and the activation of histone deacetylases. However, its role in kidney disease is unknown. In this study, we have investigated the role of BRAP and underlying mechanisms involved in cisplatin-induced AKI. BRAP was down-regulated in mice and human kidneys with AKI. Global Bc004004(homologous of C6ORF89 in mice) deletion alleviated tubular cell apoptosis and necroptosis in cisplatin-induced AKI mice, whereas local overexpression of BRAP in kidneys aggravated them. The pan-caspase inhibitor Z-VAD pretreatments attenuated cisplatin-induced blood creatinine increase and kidney injury in wild-type mice, but not in BRAP-/- mice. The activation of MLKL was magnified by Z-VAD in cisplatin-treated mice, especially in BRAP-/- mice. The cytoprotective effect of Z-VAD was more substantial than Necrostatin-1(Nec-1, an inhibitor of necroptosis) in CP-treated human kidney proximal tubular epithelial (HK2) cells. Furthermore, Nec-1pretreatment reduced the CP-induced cell death in BRAP overexpression HK2 cells but did not work in cells with normal BRAP levels. We determined that cisplatin treatment activated NF-κB subunit P65, and inhibition of P65 increased the mRNA levels of BRAP in HK2cells. ChIP assay and Dual-luciferase reporter gene assay verified P65 binding to the C6ORF89 promoter and reduced its mRNA expression upon cisplatin treatment. Next, we found that SIRT2 was downregulated in cisplatin-induced AKI, and BRAP levels directly impacted the protein levels of SIRT2. Our findings further confirmed that BRAP regulates the SIRT2 protein levels by affecting SIRT2’s interactions with E3 ubiquitin ligase HRD1 and subsequent proteasomal degradation. Collectively, our results demonstrated that BRAP played an important role in tubular cell apoptosis and necroptosis during cisplatin-induced AKI. Safe and efficient BRAP inhibitors might be effective therapeutic options for AKI.

Attenuation of renal fibrosis in mice due to lack of bombesin receptor‐activated protein homologue

Lack of Bombesin Receptor–activated Protein Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

Bombesin receptor-activated protein exacerbates cisplatin-induced AKI by regulating the degradation of SIRT2

Knockout of the BRAP homolog in mice leads to abnormal tracheal cilia

Lack of Bombesin Receptor-Activated Protein Homologous Protein Impairs Hippocampal Synaptic Plasticity and Promotes Chronic Unpredictable Mild Stress Induced Behavioral Changes in Mice

NMDA Receptor-mediated CaMKII/ERK Activation Contributes to Renal Fibrosis

Mice Overexpressing Latent Tgf-Beta 1 Are Protected Against Renal Fibrosis In Obstructive Kidney Disease

C/EBPα aggravates renal fibrosis in CKD through the NOX4-ROS-apoptosis pathway in tubular epithelial cells

Ablation of Brg1 in fibroblast/myofibroblast lineages attenuates renal fibrosis in mice with diabetic nephropathy

Biochanin A Suppresses Klf6-mediated Smad3 Transcription to Attenuate Renal Fibrosis in UUO mice

Overexpression of PRDM16 attenuates acute kidney injury progression: genetic and pharmacological approaches

The chromatin remodeling protein BRG1 mediates Ang II induced pro-fibrogenic response in renal fibroblasts

MFAP4 deficiency alleviates renal fibrosis through inhibition of NF‐κB and TGF‐β/Smad signaling pathways

Bombesin Receptor‐Activated Protein (BRAP) Modulates NF‐κB Activation in Bronchial Epithelial Cells by Enhancing HDAC Activity

AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction

Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis

BMAL1 Inhibits Renal Fibrosis and Renal Interstitial Inflammation by Targeting the ERK1/2/ELK-1/Egr-1 Axis

Abstract 07: Collecting Duct (Pro) Renin Receptor(PRR) Promotes Kidney Fibrosis Via Macrophage Alternative Activation Mediated By Soluble PRR (sPRR)-Dependent Activation Of Yap/Taz Axis

Up‐regulation of the human‐specific CHRFAM7A gene protects against renal fibrosis in mice with obstructive nephropathy

Dsba-L Mediated Renal Tubulointerstitial Fibrosis In Uuo Mice